These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18823260)
61. The effect of flow rate on drug delivery from the Pulvinal, a high-resistance dry powder inhaler. Meakin BJ; Ganderton D; Panza I; Ventura P J Aerosol Med; 1998; 11(3):143-52. PubMed ID: 10186960 [TBL] [Abstract][Full Text] [Related]
63. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method. Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548 [TBL] [Abstract][Full Text] [Related]
64. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI). Hoe S; Traini D; Chan HK; Young PM Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086 [TBL] [Abstract][Full Text] [Related]
65. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Sebti T; Amighi K Eur J Pharm Biopharm; 2006 May; 63(1):51-8. PubMed ID: 16380243 [TBL] [Abstract][Full Text] [Related]
66. Use of budesonide Turbuhaler in young children suspected of asthma. Bisgaard H; Pedersen S; Nikander K Eur Respir J; 1994 Apr; 7(4):740-2. PubMed ID: 8005258 [TBL] [Abstract][Full Text] [Related]
67. Aerosol delivery to young children by pMDI-spacer: is facemask design important? Esposito-Festen J; Ates B; van Vliet F; Hop W; Tiddens H Pediatr Allergy Immunol; 2005 Jun; 16(4):348-53. PubMed ID: 15943599 [TBL] [Abstract][Full Text] [Related]
68. Experimental investigation of design parameters on dry powder inhaler performance. Ngoc NT; Chang L; Jia X; Lau R Int J Pharm; 2013 Nov; 457(1):92-100. PubMed ID: 24055597 [TBL] [Abstract][Full Text] [Related]
69. [Functionality of inhalation aerosols is inadequate or lost at low temperature]. Lundgren HW; Holmér I; Lidén G Lakartidningen; 2001 Mar; 98(13):1508-11. PubMed ID: 11330145 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. Shrewsbury SB; Bosco AP; Uster PS Int J Pharm; 2009 Jan; 365(1-2):12-7. PubMed ID: 18786624 [TBL] [Abstract][Full Text] [Related]
72. Technological and practical challenges of dry powder inhalers and formulations. Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675 [TBL] [Abstract][Full Text] [Related]
73. Lung deposition from the Turbuhaler in children with cystic fibrosis. Devadason SG; Everard ML; MacEarlan C; Roller C; Summers QA; Swift P; Borgstrom L; Le Souëf PN Eur Respir J; 1997 Sep; 10(9):2023-8. PubMed ID: 9311496 [TBL] [Abstract][Full Text] [Related]
74. Dry powder inhalers for pulmonary drug delivery. Frijlink HW; De Boer AH Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721 [TBL] [Abstract][Full Text] [Related]
75. Effects of ramp-up of inspired airflow on in vitro aerosol dose delivery performance for certain dry powder inhalers. Ung KT; Chan HK Eur J Pharm Sci; 2016 Mar; 84():46-54. PubMed ID: 26780380 [TBL] [Abstract][Full Text] [Related]
76. The impact of patients' real-life environmental temperature and humidity use conditions of tiotropium dry powder inhaler on its aerosol emission characteristics. Ammari WG; Mohammad MK; Tayyem RF Eur J Pharm Sci; 2019 May; 133():137-144. PubMed ID: 30946963 [TBL] [Abstract][Full Text] [Related]
77. Aerosol delivery devices in the treatment of asthma. Hess DR Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026 [TBL] [Abstract][Full Text] [Related]
78. Peak inspiratory flow rate and the ability to use the Turbuhaler in Thai children aged 3-7 years. Tantibhaedhyangkul U; Chatchatee P; Choketeeraswad T; Ngamphaiboon J J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S201-7. PubMed ID: 12929990 [TBL] [Abstract][Full Text] [Related]
79. [The evaluation of useful breath actuated inhalers by preschool asthmatic children]. Doniec Z; Kurzawa R; Jedrys-Kłucjasz U; Pisiewicz K; Mazurek E; Widerska-Kurzawa A Pol Merkur Lekarski; 2005 Apr; 18(106):389-92. PubMed ID: 16161917 [TBL] [Abstract][Full Text] [Related]
80. Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry. New A; Prime D; Zomer S; Elder D; Donovan R; Freney E Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3873-82. PubMed ID: 19003851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]